Press Releases
New Evidence on MeMed BV’s Role in Supporting Emergency Medicine Clinical Decisions Unveiled at ACEP 2025
MeMed Completes Development of the First Computational Host-Response Test Using a Fingerstick Sample to Differentiate Bacterial and Viral Infections: MeMed BV Flex™
MeMed BV Surpasses 100,000 Patient Tests, Underscoring Adoption of Rapid Host-Response Diagnostics
MeMed BV Proven to Optimize Antibiotic Use, Outperform Standard Care, and Cut Costs in New Studies
MeMed Expands Advisory Board with Key Leaders to Advance Host-Response Diagnostics for Sepsis and AMR
FDA Grants Breakthrough Device Designation to MeMed Severity Test for Patients with Suspected Sepsis
MeMed BV Test Demonstrates Antibiotic Overuse Reduction in First US Interventional Trial
Beckman Coulter and MeMed Extend Partnership Advancing Host Immune Response Diagnostics
MeMed Further Solidifies Board of Directors With New Appointment
MeMed Bolsters Leadership Team
MeMed Awarded US BARDA Contract
FDA Clears MeMed BV Direct from Whole Blood
Nutex Health Announces Agreement with MeMed to Adopt Pioneering MeMed BV® Test Across its Network of 19 sites
Clinical Data Validate Pioneering MeMed BV® Technology Improves Diagnosis of Pediatric Patients with Fever in the Emergency Department
Beckman Coulter and MeMed to Expand Access to Proven Host Immune Response Diagnostic Able to Distinguish Between Bacterial and Viral Infections
No results found.